Science and Research

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

The purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis, to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these participants.

Study details
Study-ID: NCT04308681, 2019-003992-21
DZL Disease Area: DPLD
Study Type: Interventional
DZL Role: DZL recruiting center
Funding: Externally - industry
DZL Participating Sites: ARCN
Start Date: 29.07.2020
Completion Date: 22.09.2023
Status: Closed
Link to Study


chevron-down